The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Lipoxin A4: A New Class of Ligand for the Ah Receptor
Abstract
The Ah receptor is a ligand-activated transcription factor that mediates many of the biological actions of a large class of environmental compounds. Support for a role of the Ah receptor in normal physiology also has been reported, but an endogenous regulating ligand has not been identified. We have examined candidate endogenous lipophilic substances and report here the ability of the arachidonic acid metabolite, lipoxin A4, to bind to and activate the Ah receptor in Hepa-1 cells. Lipoxin A4 produced a concentration-dependent response in a DRE-driven CAT reporter construct, with a greater than 10-fold increase in CAT activity at 0. 3 microM. Lipoxin A4 transformed the Ah receptor to an active DRE-binding form in a concentration-dependent manner as indicated by gel mobility shift analysis. Results of Ah receptor competitive binding experiments indicated that at a concentration of 100 nM, lipoxin A4 produced a half-maximum displacement (EC50) of [3H]TCDD binding. Results of Northern blot analyses indicated a transient increase in mRNA levels of the Ah receptor-responsive gene CYP1A1, which peaked at 4 h, consistent with the kinetics observed for lipoxin A4-induced CYP1A1 enzyme activity. Further, lipoxin A4 was found to be a competitive inhibitor for the CYP1A1 enzyme, with a calculated Ki = 1.1 microM. These results establish lipoxin A4 as a new class of Ah receptor ligand, one that differs dramatically from classical Ah receptor ligands.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Poland, A., & Knutson, J. C. (1982) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.22.040182.002505 · Cited by 2,515
Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y. Y., Jabs, E. W., Li, X., Yin, H., Cody, C. W., & Greenlee, W. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36803-5 · Cited by 508
Transcriptional regulation of the rat NAD(P)H:quinone reductase gene
Favreau, L. V., & Pickett, C. B. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)64358-7 · Cited by 497
Denison, M. S., Fisher, J. M., & Whitlock, J. P. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77819-3 · Cited by 451
Takano, T., Fiore, S., Maddox, J. F., Brady, H. R., Petasis, N. A., & Serhan, C. N. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1693 · Cited by 431
Serhan, C. N., & Sheppard, K. A. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114503 · Cited by 313
Gasiewicz, T. A., & Neal, R. A. (1982) · Analytical Biochemistry · doi:10.1016/0003-2697(82)90212-3 · Cited by 165
Israel, D. I., & Whitlock, J. P. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)91022-7 · Cited by 162
Cytochrome P450 and the Metabolism of Arachidonic Acid and Oxygenated Eicosanoids
Capdevila, J. H., Zeldin, D. C., Makita, K., Karara, A., & Falck, J. R. (1995) · Springer eBooks · doi:10.1007/978-1-4757-2391-5_13 · Cited by 44
Bonati, L., Fraschini, E., Lasagni, M., & Pitea, D. (1994) · Journal of Molecular Structure THEOCHEM · doi:10.1016/0166-1280(94)80172-x · Cited by 17
Cited by
Denison, M. S., & Nagy, S. R. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135828 · Cited by 1,895
Ye, R. D., Boulay, F., Wang, J. M., Dahlgren, C., Gerard, C., Parmentier, M., Serhan, C. N., & Murphy, P. M. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001578 · Cited by 764
The Search for Endogenous Activators of the Aryl Hydrocarbon Receptor
Nguyen, L. P., & Bradfield, C. A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx7001965 · Cited by 709
AhR signaling pathways and regulatory functions
Larigot, L., Juricek, L., Dairou, J., & Coumoul, X. (2018) · Biochimie Open · doi:10.1016/j.biopen.2018.05.001 · Cited by 562
Thematic Review Series: Proteomics. An integrated omics analysis of eicosanoid biology
Buczynski, M. W., Dumlao, D. S., & Dennis, E. A. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900004-jlr200 · Cited by 530
The Aryl Hydrocarbon Receptor in Barrier Organ Physiology, Immunology, and Toxicology
Esser, C., & Rannug, A. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009001 · Cited by 501
Ligand binding and activation of the Ah receptor
Denison, M. S., Pandini, A., Nagy, S. R., Baldwin, E. P., & Bonati, L. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00063-7 · Cited by 485
The Lipoxin Receptor ALX: Potent Ligand-Specific and Stereoselective Actions in Vivo
Chiang, N., Serhan, C. N., Dahlén, S.-E., Drazen, J. M., Hay, D. W. P., Rovati, G. E., Shimizu, T., Yokomizo, T., & Brink, C. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.4 · Cited by 464
Serhan, C. N. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2005.05.002 · Cited by 454
The aryl hydrocarbon receptor: a perspective on potential roles in the immune system
Stevens, E. A., Mezrich, J. D., & Bradfield, C. A. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03054.x · Cited by 413
Indirubin and Indigo Are Potent Aryl Hydrocarbon Receptor Ligands Present in Human Urine
Adachi, J., Mori, Y., Matsui, S., Takigami, H., Fujino, J., Kitagawa, H., Miller, C. A., Kato, T., Saeki, K., & Matsuda, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100238200 · Cited by 407
Immune response and immunopathology during toxoplasmosis
Dupont, C. D., Christian, D. A., & Hunter, C. A. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0339-3 · Cited by 359
Emerging role of 12/15-Lipoxygenase (ALOX15) in human pathologies
Singh, N. K., & Rao, G. N. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2018.11.001 · Cited by 345
(CONTAM), E. P. O. C. I. T. F. C., Knutsen, H. K., Alexander, J., Barregård, L., Bignami, M., Brüschweiler, B., Ceccatelli, S., Cottrill, B., Dinovi, M., Edler, L., et al. (2018) · EFSA Journal · doi:10.2903/j.efsa.2018.5333 · Cited by 342
Old and new generation lipid mediators in acute inflammation and resolution
Stables, M. J., & Gilroy, D. W. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.07.005 · Cited by 334
Aryl Hydrocarbon Receptor Control of Adaptive Immunity
Quintana, F. J., & Sherr, D. H. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007823 · Cited by 329
The Aryl Hydrocarbon Receptor: Connecting Immunity to the Microenvironment
Shinde, R., & McGaha, T. L. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.10.010 · Cited by 329
Effects of Low-Dose Aspirin on Acute Inflammatory Responses in Humans
Morris, T., Stables, M., Hobbs, A., de Souza, P., Colville-Nash, P., Warner, T., Newson, J., Bellingan, G., & Gilroy, D. W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900477 · Cited by 322
Calder, P. C. (2020) · Essays in Biochemistry · doi:10.1042/ebc20190083 · Cited by 321
Anti-inflammatory actions of lipoxin A4 and aspirin-triggered lipoxin are SOCS-2 dependent
Machado, F. S., Johndrow, J. E., Esper, L., Dias, A., Bafica, A., Serhan, C. N., & Aliberti, J. (2006) · Nature Medicine · doi:10.1038/nm1355 · Cited by 310
An introduction to the molecular basics of aryl hydrocarbon receptor biology
Abel, J., & Haarmann-Stemmann, T. (2010) · Biological Chemistry · doi:10.1515/bc.2010.128 · Cited by 296
Molecular mechanisms of AhR functions in the regulation of cytochrome P450 genes
Fujii-Kuriyama, Y., & Mimura, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.162 · Cited by 290
International Union of Pharmacology XXXVII. Nomenclature for Leukotriene and Lipoxin Receptors
Brink, C., Dahlén, S.-E., Drazen, J., Evans, J. F., Hay, D. W. P., Nicosia, S., Serhan, C. N., Shimizu, T., & Yokomizo, T. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.8 · Cited by 286
The Formyl Peptide Receptors: Diversity of Ligands and Mechanism for Recognition
He, H.-Q., & Ye, R. (2017) · Molecules · doi:10.3390/molecules22030455 · Cited by 279
Nebert, D. W. (2017) · Progress in Lipid Research · doi:10.1016/j.plipres.2017.06.001 · Cited by 275
A ligand for the aryl hydrocarbon receptor isolated from lung
Song, J., Clagett-Dame, M., Peterson, R. E., Hahn, M. E., Westler, W. M., Sicinski, R. R., & DeLuca, H. F. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.232562899 · Cited by 264
Chiang, N., Fierro, I. M., Gronert, K., & Serhan, C. N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1197 · Cited by 260
Kawajiri, K., & Fujii-Kuriyama, Y. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.03.038 · Cited by 197
Grishanova, A. Y., & Perepechaeva, M. L. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126719 · Cited by 130
Furness, S. G. B., & Whelan, F. (2009) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.09.004 · Cited by 63
AHR Ligands: Promiscuity in Binding and Diversity in Response
DeGroot, D., He, G., Fraccalvieri, D., Bonati, L., Pandini, A., & Denison, M. S. (2011) · The AH Receptor in Biology and Toxicology · doi:10.1002/9781118140574.ch4 · Cited by 43
Metadata
- Authors
- Schaldach, C. M., Riby, J., & Bjeldanes, L. F.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1999-05-18
- Volume
- 38
- Issue
- 23
- Pages
- 7594-7600
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W2020873521
- Cited by
- 264
- References
- 11
- FWCI
- 7.49
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.